Detection of male 2+0 and 1+0 carriers for spinal muscular atrophy by digital PCR

Clin Genet. 2023 Jul;104(1):90-99. doi: 10.1111/cge.14342. Epub 2023 Apr 13.

Abstract

Spinal muscular atrophy (SMA) is an autosomal recessive disease with a high carrier frequency. While current screening methods can identify 1+0 carriers, detecting 2+0 genotypes remains challenging, highlighting the need for additional research. Herein, we applied Digital Polymerase Chain Reaction (dPCR) to develop a novel approach for the detection of male carriers (DMC), especially for those with a 2+0 genotype. The clinical utility of DMC was evaluated in 39 semen samples. Multiple ligation-dependent probe amplification (MLPA) and pedigree analysis were performed on genomic DNA from 111 males and their family members. DMC identified 1+1, 2+1, and 1+0 genotypes in 21, 1, and 8 subjects. Importantly, seven men were identified as 2+0 carriers, while two men were excluded from the 2+0 carrier status. The results of DMC were consistent with those of MLPA and pedigree analysis. DMC provides an inexpensive and accurate method for determining the 2+0 and 1+0 genotypes.

Keywords: 1+0 genotype; 2+0 genotype; carrier screening; semen; spinal muscular atrophy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Genetic Carrier Screening / methods
  • Genotype
  • Humans
  • Male
  • Muscular Atrophy, Spinal* / diagnosis
  • Muscular Atrophy, Spinal* / genetics
  • Nucleic Acid Amplification Techniques
  • Polymerase Chain Reaction / methods
  • Survival of Motor Neuron 1 Protein / genetics

Substances

  • Survival of Motor Neuron 1 Protein